Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Finding the target after screening the phenotype.

Charles P Hart1

  • 1Galileo Pharmaceuticals, Santa Clara, CA 95054, USA. chart@thresholdpharm.com

Drug Discovery Today
|April 6, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Selective Tumor Hypoxia Targeting by Hypoxia-Activated Prodrug TH-302 Inhibits Tumor Growth in Preclinical Models of Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Retraction: Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy.

Oncotarget·2024
Same author

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.

JCI insight·2023
Same author

Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of Evofosfamide.

Molecular pharmacology·2019
Same author

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.

JCI insight·2018
Same author

Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice.

Cancer research·2018
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
See all related articles

Phenotype-based drug screening identifies new drug leads by observing cellular changes, but pinpointing the molecular target remains challenging. This review explores direct and indirect methods for target identification after phenotypic screening.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Drug Discovery

Background:

  • Traditional drug lead screening focuses on known molecular targets.
  • Phenotypic screening, observing organismal or cellular changes, is experiencing a resurgence.
  • Identifying the specific molecular targets of phenotypic screening hits is a significant challenge.

Purpose of the Study:

  • To review and compare various technologies and approaches for molecular target identification following phenotypic screening.
  • To highlight the advantages and disadvantages of different target identification strategies.
  • To provide insights through case studies of successful target identification efforts.

Main Methods:

  • Direct approaches: affinity chromatography, expression cloning, and protein microarrays to analyze compound-target interactions.

Related Experiment Videos

  • Indirect approaches: comparing compound activity profiles with genomic databases and genetic perturbation data.
  • Case study analysis to illustrate the practical application and outcomes of these methods.

    • Main Results:

    • Both direct and indirect methods offer viable strategies for target identification.
    • Each approach presents unique advantages and limitations regarding sensitivity, specificity, and throughput.
    • The choice of method depends on the specific compound, biological system, and available resources.

    Conclusions:

    • Effective target identification is crucial for advancing phenotypic screening in drug discovery.
    • A combination of direct and indirect approaches may be optimal for complex cases.
    • Continued technological development is essential for improving the efficiency and accuracy of target identification.